Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4424-4429, Vol. 75, No. 9
Department of Biomedicine and Retrovirus
Center, University of Pisa, Pisa, Italy
Received 8 December 2000/Accepted 30 January 2001
In the feline immunodeficiency virus system, immunization with a
fixed-infected-cell vaccine conferred protection against virulent
homologous challenge but the immune effectors involved remained
elusive. In particular, few or no neutralizing antibodies were detected
in sera from vaccinated cats. Here we show that, when preadsorbed with
selected feline cells, the same sera revealed clearly evident
virus-neutralizing activity. Because high titers of neutralizing
antibody in cell-adsorbed sera from 23 cats immunized with
fixed-infected-cell or whole-inactivated-virus vaccines correlated with
protection, it is likely that they were more important for protection
than formerly realized. In vitro, the fixed-cell vaccine efficiently
removed neutralizing antibody from immune sera while the
whole-inactivated-virus vaccine was much less effective.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.9.4424-4429.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
AIDS Vaccination Studies Using an Ex Vivo Feline
Immunodeficiency Virus Model: Reevaluation of Neutralizing Antibody
Levels Elicited by a Protective and a Nonprotective Vaccine after
Removal of Antisubstrate Cell Antibodies
*
Corresponding author. Mailing address: Dipartimento di
Biomedicina, Università di Pisa, Via San Zeno 37, I-56127 Pisa,
Italy. Phone: 39-050-553562. Fax: 39-050-559455. E-mail:
bendinelli{at}biomed.unipi.it.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»